Financials

  • Market Capitalization 219.69 M
  • Employee 87
  • Founded 2015
  • CEO N/A
  • Website www.kerostx.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00H1HP9G9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
8.85
Rapporto prezzo/fatturato
3.16

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3571
DTIL
Precision BioSciences, Inc. - Common Stock
8.59 USD-1.94%+4.76%+39.00%+86.74%221.64 M USD
3575
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
8.93 USD-7.37%-5.40%+4.20%+114.66%220.72 M USD
3580
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.35 USD-1.36%0.00%+2.84%-46.49%219.12 M USD
3583
AVXL
Anavex Life Sciences Corp. - Common Stock
2.35 USD-6.00%-12.64%-7.84%-79.39%217.78 M USD

Notizie